دورية أكاديمية
Rapid-response surveillance of the first US test market for VLN cigarettes.
| العنوان: | Rapid-response surveillance of the first US test market for VLN cigarettes. |
|---|---|
| المؤلفون: | Henriksen L; Stanford Prevention Research Center, Stanford University School of Medicine, Palo Alto, California 94304, USA lhenriksen@stanford.edu., Johnson TO; Stanford Prevention Research Center, Stanford University School of Medicine, Palo Alto, California 94304, USA., Mahoney M; Public Health Policy, Minneapolis, Minnesota, USA., Schleicher NC; Stanford Prevention Research Center, Stanford University School of Medicine, Palo Alto, California 94304, USA., Ali A; Stanford Prevention Research Center, Stanford University School of Medicine, Palo Alto, California 94304, USA., Prochaska JJ; Stanford Prevention Research Center, Stanford University School of Medicine, Palo Alto, California 94304, USA. |
| المصدر: | Tobacco control [Tob Control] 2024 Jun 20; Vol. 33 (4), pp. 549-552. Date of Electronic Publication: 2024 Jun 20. |
| نوع المنشور: | Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: BMJ Pub. Group Country of Publication: England NLM ID: 9209612 Publication Model: Electronic Cited Medium: Internet ISSN: 1468-3318 (Electronic) Linking ISSN: 09644563 NLM ISO Abbreviation: Tob Control Subsets: MEDLINE |
| أسماء مطبوعة: | Original Publication: London : BMJ Pub. Group, c1992- |
| مواضيع طبية MeSH: | Tobacco Products*/economics , Commerce*/economics , Commerce*/statistics & numerical data , Advertising*, Humans ; United States ; Menthol ; Marketing/methods ; Chicago ; Tobacco Industry/economics ; United States Food and Drug Administration |
| مستخلص: | Introduction: VLN King menthol and non-menthol are the first combustible cigarettes to receive US Food and Drug Administration (FDA) authorisation as modified risk tobacco products. Focusing on the first retail test market, this study characterised VLN advertising, product placement, discounts and price. Methods: All Chicago-area Circle K stores (n=133) were telephoned to assess whether they sold VLN. Single-pack price of non-menthol was obtained in 57 of 100 stores that sold VLN. In fall 2022, trained data collectors visited those 57 stores to assess VLN product placement, advertising, discounts and prices. Paired t-tests compared observed VLN price with telephone price and to price of other cigarette brands. Results: Nearly all stores (91.1%) displayed exterior advertisements for VLN, and 41.1% displayed interior advertising, with 8.9% of stores advertising VLN in the power wall but never in the header row. VLN cigarettes were displayed in the power wall exclusively and among high-nicotine cigarettes. Some VLN marketing claims were not FDA-authorised. VLN advertised a sweepstakes offer and rewards programme. Most stores (85.7%) offered VLN discounts. VLN was priced like a premium brand (mean=$10.90, SD=$1.53), and prices obtained by telephone did not differ from observed prices several months later. Conclusions: Retail marketing strategies for VLN mimic those for high-nicotine cigarettes. Deviations from FDA-authorised marketing claims were evident. Surveillance in future test markets is recommended to assess compliance with marketing claims and examine relative price and discount offers. Of interest is how premium-priced, low-nicotine cigarettes stand to compete in a market dominated by cheaper high-nicotine cigarettes. Competing Interests: Competing interests: JJP has provided consultation to pharmaceutical and technology companies that make medications and other treatments for quitting smoking and has served as an expert witness in lawsuits against the tobacco companies. (© Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ.) |
| References: | Addiction. 2010 Feb;105(2):343-55. (PMID: 20078491) Nicotine Tob Res. 2017 Nov 01;19(11):1330-1337. (PMID: 28444233) N Engl J Med. 2015 Oct;373(14):1340-9. (PMID: 26422724) MMWR Morb Mortal Wkly Rep. 2017 Jan 06;65(52):1457-1464. (PMID: 28056007) Nicotine Tob Res. 2018 Jun 7;20(7):843-850. (PMID: 28340034) Addiction. 2017 Feb;112(2):349-359. (PMID: 27741367) Tob Control. 2015 Dec;24(e4):e241-5. (PMID: 24638964) Tob Control. 2023 Sep;32(5):645-651. (PMID: 35641117) Nicotine Tob Res. 2021 Jun 8;23(7):1123-1132. (PMID: 33165612) |
| معلومات مُعتمدة: | P01 CA225597 United States CA NCI NIH HHS |
| فهرسة مساهمة: | Keywords: Advertising and Promotion; Nicotine; Price; Surveillance and monitoring; Tobacco industry |
| المشرفين على المادة: | 1490-04-6 (Menthol) |
| تواريخ الأحداث: | Date Created: 20230317 Date Completed: 20240620 Latest Revision: 20240714 |
| رمز التحديث: | 20240714 |
| مُعرف محوري في PubMed: | PMC11242917 |
| DOI: | 10.1136/tc-2022-057888 |
| PMID: | 36927515 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder | تدمد: | 1468-3318 |
|---|---|
| DOI: | 10.1136/tc-2022-057888 |